Fig. 1: Bispecific antibodies and their tumour specific antigenic targets on myeloma cells.
From: Bispecific antibodies in the treatment of multiple myeloma
This figure depicts the various myeloma cell target antigens that have been studied preclinically or clinically, along with the BsAbs constructs used and their associated effector cell antigen targets.
